Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Academic Article uri icon

Overview

MeSH Major

  • Heart Failure
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha

abstract

  • The results of RENEWAL rule out a clinically relevant benefit of etanercept on the rate of death or hospitalization due to chronic heart failure.

publication date

  • April 6, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000124490.27666.B2

PubMed ID

  • 15023878

Additional Document Info

start page

  • 1594

end page

  • 602

volume

  • 109

number

  • 13